Cedar Health Research - Euless | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity	Body Weight, Nutritional and Metabolic Diseases, Obesity, Abdominal, Overweight, Pathological Conditions, Signs and Symptoms, Prehypertension, Signs and Symptoms, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, prediabetes syndrome, vascular disorder	Recruiting	Phase 3	2026-10-08		NCT07794579
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition	Active, not recruiting	Phase 2	2026-09-14		NCT07575932
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older	Clostridoides Difficile Associated Disease	Recruiting	Phase 3	2026-09-09		NCT07282665
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition	Active, not recruiting	Phase 3	2026-04-17		NCT07232719
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age	COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia	Active, not recruiting	Phase 3	2026-04-13		NCT07300839